Cargando…
Comparison of the dipeptidyl peptidase-4 gene methylation levels between severely obese subjects with and without the metabolic syndrome
BACKGROUND: The dipeptidyl peptidase-4 (DPP4) enzyme is a novel adipokine potentially involved in the development of the metabolic syndrome (MetS). Previous observations demonstrated higher visceral adipose tissue (VAT) DPP4 gene expression in non-diabetic severely obese men with (MetS+) vs. without...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637825/ https://www.ncbi.nlm.nih.gov/pubmed/23379505 http://dx.doi.org/10.1186/1758-5996-5-4 |
_version_ | 1782475786586947584 |
---|---|
author | Turcot, Valérie Tchernof, André Deshaies, Yves Pérusse, Louis Bélisle, Alexandre Marceau, Picard Hould, Frédéric-Simon Lebel, Stéfane Vohl, Marie-Claude |
author_facet | Turcot, Valérie Tchernof, André Deshaies, Yves Pérusse, Louis Bélisle, Alexandre Marceau, Picard Hould, Frédéric-Simon Lebel, Stéfane Vohl, Marie-Claude |
author_sort | Turcot, Valérie |
collection | PubMed |
description | BACKGROUND: The dipeptidyl peptidase-4 (DPP4) enzyme is a novel adipokine potentially involved in the development of the metabolic syndrome (MetS). Previous observations demonstrated higher visceral adipose tissue (VAT) DPP4 gene expression in non-diabetic severely obese men with (MetS+) vs. without (MetS−) MetS. DPP4 mRNA abundance in VAT correlated also with CpG site methylation levels (%Meth) localized within and near its exon 2 (CpG(94) to CpG(102)) in non-diabetic severely obese women, regardless of their MetS status. The actual study tested whether DPP4 %Meth levels in VAT are different between MetS− and MetS+ non-diabetic severely obese subjects, whether variable metabolic and plasma lipid profiles are observed between DPP4 %Meth quartiles, and whether correlation exists in DPP4 %Meth levels between VAT and white blood cells (WBCs). METHODS: DNA was extracted from the VAT of 26 men (MetS−: n=12, MetS+: n=14) and 79 women (MetS−: n=60; MetS+: n=19), as well as from WBCs in a sub-sample of 17 women (MetS−: n=9; MetS+: n=8). The %Meth levels of CpG(94) to CpG(102) were assessed by pyrosequencing of sodium bisulfite-treated DNA. ANOVA analyses were used to compare the %Meth of CpGs between MetS− and MetS+ groups, and to compare the metabolic phenotype and plasma lipid levels between methylation quartiles. Pearson correlation coefficient analyses were computed to test the relationship between VAT and WBCs CpG(94-102) %Meth levels. RESULTS: No difference was observed in CpG(94-102 )%Meth levels between MetS− and MetS+ subjects in VAT (P=0.67), but individuals categorized into CpG(94-102) %Meth quartiles had variable plasma total-cholesterol concentrations (P=0.04). The %Meth levels of four CpGs in VAT were significantly correlated with those observed in WBCs (r=0.55−0.59, P≤0.03). CONCLUSIONS: This study demonstrated that %Meth of CpGs localized within and near the exon 2 of the DPP4 gene in VAT are not associated with MetS status. The actual study also revealed an association between the %Meth of this locus with plasma total-cholesterol in severe obesity, which suggests a link between the DPP4 gene and plasma lipid levels. |
format | Online Article Text |
id | pubmed-3637825 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-36378252013-04-28 Comparison of the dipeptidyl peptidase-4 gene methylation levels between severely obese subjects with and without the metabolic syndrome Turcot, Valérie Tchernof, André Deshaies, Yves Pérusse, Louis Bélisle, Alexandre Marceau, Picard Hould, Frédéric-Simon Lebel, Stéfane Vohl, Marie-Claude Diabetol Metab Syndr Research BACKGROUND: The dipeptidyl peptidase-4 (DPP4) enzyme is a novel adipokine potentially involved in the development of the metabolic syndrome (MetS). Previous observations demonstrated higher visceral adipose tissue (VAT) DPP4 gene expression in non-diabetic severely obese men with (MetS+) vs. without (MetS−) MetS. DPP4 mRNA abundance in VAT correlated also with CpG site methylation levels (%Meth) localized within and near its exon 2 (CpG(94) to CpG(102)) in non-diabetic severely obese women, regardless of their MetS status. The actual study tested whether DPP4 %Meth levels in VAT are different between MetS− and MetS+ non-diabetic severely obese subjects, whether variable metabolic and plasma lipid profiles are observed between DPP4 %Meth quartiles, and whether correlation exists in DPP4 %Meth levels between VAT and white blood cells (WBCs). METHODS: DNA was extracted from the VAT of 26 men (MetS−: n=12, MetS+: n=14) and 79 women (MetS−: n=60; MetS+: n=19), as well as from WBCs in a sub-sample of 17 women (MetS−: n=9; MetS+: n=8). The %Meth levels of CpG(94) to CpG(102) were assessed by pyrosequencing of sodium bisulfite-treated DNA. ANOVA analyses were used to compare the %Meth of CpGs between MetS− and MetS+ groups, and to compare the metabolic phenotype and plasma lipid levels between methylation quartiles. Pearson correlation coefficient analyses were computed to test the relationship between VAT and WBCs CpG(94-102) %Meth levels. RESULTS: No difference was observed in CpG(94-102 )%Meth levels between MetS− and MetS+ subjects in VAT (P=0.67), but individuals categorized into CpG(94-102) %Meth quartiles had variable plasma total-cholesterol concentrations (P=0.04). The %Meth levels of four CpGs in VAT were significantly correlated with those observed in WBCs (r=0.55−0.59, P≤0.03). CONCLUSIONS: This study demonstrated that %Meth of CpGs localized within and near the exon 2 of the DPP4 gene in VAT are not associated with MetS status. The actual study also revealed an association between the %Meth of this locus with plasma total-cholesterol in severe obesity, which suggests a link between the DPP4 gene and plasma lipid levels. BioMed Central 2013-02-04 /pmc/articles/PMC3637825/ /pubmed/23379505 http://dx.doi.org/10.1186/1758-5996-5-4 Text en Copyright © 2013 Turcot et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Turcot, Valérie Tchernof, André Deshaies, Yves Pérusse, Louis Bélisle, Alexandre Marceau, Picard Hould, Frédéric-Simon Lebel, Stéfane Vohl, Marie-Claude Comparison of the dipeptidyl peptidase-4 gene methylation levels between severely obese subjects with and without the metabolic syndrome |
title | Comparison of the dipeptidyl peptidase-4 gene methylation levels between severely obese subjects with and without the metabolic syndrome |
title_full | Comparison of the dipeptidyl peptidase-4 gene methylation levels between severely obese subjects with and without the metabolic syndrome |
title_fullStr | Comparison of the dipeptidyl peptidase-4 gene methylation levels between severely obese subjects with and without the metabolic syndrome |
title_full_unstemmed | Comparison of the dipeptidyl peptidase-4 gene methylation levels between severely obese subjects with and without the metabolic syndrome |
title_short | Comparison of the dipeptidyl peptidase-4 gene methylation levels between severely obese subjects with and without the metabolic syndrome |
title_sort | comparison of the dipeptidyl peptidase-4 gene methylation levels between severely obese subjects with and without the metabolic syndrome |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637825/ https://www.ncbi.nlm.nih.gov/pubmed/23379505 http://dx.doi.org/10.1186/1758-5996-5-4 |
work_keys_str_mv | AT turcotvalerie comparisonofthedipeptidylpeptidase4genemethylationlevelsbetweenseverelyobesesubjectswithandwithoutthemetabolicsyndrome AT tchernofandre comparisonofthedipeptidylpeptidase4genemethylationlevelsbetweenseverelyobesesubjectswithandwithoutthemetabolicsyndrome AT deshaiesyves comparisonofthedipeptidylpeptidase4genemethylationlevelsbetweenseverelyobesesubjectswithandwithoutthemetabolicsyndrome AT perusselouis comparisonofthedipeptidylpeptidase4genemethylationlevelsbetweenseverelyobesesubjectswithandwithoutthemetabolicsyndrome AT belislealexandre comparisonofthedipeptidylpeptidase4genemethylationlevelsbetweenseverelyobesesubjectswithandwithoutthemetabolicsyndrome AT marceaupicard comparisonofthedipeptidylpeptidase4genemethylationlevelsbetweenseverelyobesesubjectswithandwithoutthemetabolicsyndrome AT houldfredericsimon comparisonofthedipeptidylpeptidase4genemethylationlevelsbetweenseverelyobesesubjectswithandwithoutthemetabolicsyndrome AT lebelstefane comparisonofthedipeptidylpeptidase4genemethylationlevelsbetweenseverelyobesesubjectswithandwithoutthemetabolicsyndrome AT vohlmarieclaude comparisonofthedipeptidylpeptidase4genemethylationlevelsbetweenseverelyobesesubjectswithandwithoutthemetabolicsyndrome |